UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Follicular thyroid carcinoma with skull metastases

Endocrine Journal, 2015, Vol.62(4), pp.363-369

2015

Volltextzugriff (PDF)

Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer

Endocrine-related cancer, 2017-09, Vol.24 (9), p.485-493

2017

Volltextzugriff (PDF)

Targeted therapy: A new hope for thyroid carcinomas

Critical reviews in oncology/hematology, 2015-04, Vol.94 (1), p.55-63

2015

Volltextzugriff (PDF)

Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers

International journal of molecular sciences, 2013-11, Vol.14 (11), p.21727-21740

2013

Volltextzugriff (PDF)

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer

Cancers, 2019-06, Vol.11 (6), p.785

2019

Volltextzugriff (PDF)

Fathoming the link between anthropogenic chemical contamination and thyroid cancer

Critical reviews in oncology/hematology, 2020-06, Vol.150, p.102950, Article 102950

2020

Volltextzugriff (PDF)

Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome

Cancer biology & therapy, 2010-03, Vol.9 (6), p.423-429

2010

Volltextzugriff (PDF)

Follicular thyroid carcinoma with skull metastases

ENDOCRINE JOURNAL, 2015-04, Vol.62 (4), p.363-369

2015

Volltextzugriff (PDF)

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules

Chemosphere (Oxford), 2019-03, Vol.218, p.885-894

2019

Volltextzugriff (PDF)

Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm

Critical reviews in oncology/hematology, 2021-06, Vol.162, p.103353-103353, Article 103353

2021

Volltextzugriff (PDF)

Gene expression profile in metastatic and non-metastatic parathyroid carcinoma

Endocrine-related cancer, 2021-02, Vol.28 (2), p.111-134

2021

Volltextzugriff (PDF)

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2017-02, Vol.102 (2), p.661-671

2017

Volltextzugriff (PDF)

A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis

Thyroid (New York, N.Y.), 2023-11, Vol.33 (11), p.1318

2023

Volltextzugriff (PDF)

Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7‐gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy

Cancer cytopathology, 2020-02, Vol.128 (2), p.107-118

2020

Volltextzugriff (PDF)

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome

Endocrine, 2018-10, Vol.62 (1), p.71-75

2018

Volltextzugriff (PDF)

Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients

Clinical endocrinology (Oxford), 2019-12, Vol.91 (6), p.851-859

2019

Volltextzugriff (PDF)

New Insight into the Treatment of Advanced Differentiated Thyroid Cancer

Journal of Thyroid Research, 2012-01, Vol.2012, p.437569-8

2012

Volltextzugriff (PDF)

The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study

Endocrine, 2018-10, Vol.62 (1), p.46-56

2018

Volltextzugriff (PDF)

Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines

Journal of Thyroid Research, 2012-01, Vol.2012, p.512401-8

2012

Volltextzugriff (PDF)

Multifocality and Hashimoto’s thyroiditis as independent predictors of structural recurrence in a cohort of low risk intrathyroidal papillary thyroid cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17577-e17577

2017

Volltextzugriff (PDF)

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion

Oncotarget, 2018-04, Vol.9 (29), p.20721-20733

2018

Volltextzugriff (PDF)

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

Endocrine, 2017-09, Vol.57 (3), p.539-543

2017

Volltextzugriff (PDF)

Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology

Oncotarget, 2018-04, Vol.9 (27), p.19255-19262

2018

Volltextzugriff (PDF)

Metastatic eccrine porocarcinoma: report of a case and review of the literature

World journal of surgical oncology, 2011-03, Vol.9 (1), p.32-32, Article 32

2011

Volltextzugriff (PDF)

Data-Driven Thyroglobulin Cutoffs for Low- and Intermediate-Risk Thyroid Cancer Follow-Up: ITCO Real-World Analysis

The journal of clinical endocrinology and metabolism, 2024-08

2024

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Follicular thyroid carcinoma with skull metastases

Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer

Targeted therapy: A new hope for thyroid carcinomas

Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer

Fathoming the link between anthropogenic chemical contamination and thyroid cancer

Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome

Follicular thyroid carcinoma with skull metastases

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules

Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm

Gene expression profile in metastatic and non-metastatic parathyroid carcinoma

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer

A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis

Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7‐gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome

Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients

New Insight into the Treatment of Advanced Differentiated Thyroid Cancer

The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study

Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines

Multifocality and Hashimoto’s thyroiditis as independent predictors of structural recurrence in a cohort of low risk intrathyroidal papillary thyroid cancer

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology

Metastatic eccrine porocarcinoma: report of a case and review of the literature

Data-Driven Thyroglobulin Cutoffs for Low- and Intermediate-Risk Thyroid Cancer Follow-Up: ITCO Real-World Analysis

Suchergebnisse filtern